Certain embodiments disclosed herein relate generally to valve prostheses. In particular, certain embodiments relate to an anchoring system for use with replacement heart valves, such as for the mitral valve, wherein the anchoring system is configured to preserve the natural shape of the heart.
Human heart valves, which include the aortic, pulmonary, mitral and tricuspid valves, function essentially as one-way valves operating in synchronization with the pumping heart. The valves allow blood to flow downstream, but block blood from flowing upstream. Diseased heart valves exhibit impairments such as narrowing of the valve or regurgitation, which inhibit the valves' ability to control blood flow. Such impairments reduce the heart's blood-pumping efficiency and can be a debilitating and life threatening condition. For example, valve insufficiency can lead to conditions such as heart hypertrophy and dilation of the ventricle. Thus, extensive efforts have been made to develop methods and apparatuses to repair or replace impaired heart valves.
Prostheses exist to correct problems associated with impaired heart valves. For example, mechanical and tissue-based heart valve prostheses can be used to replace impaired native heart valves. More recently, substantial effort has been dedicated to developing replacement heart valves, particularly tissue-based replacement heart valves that can be delivered with less trauma to the patient than through open heart surgery. Replacement valves are being designed to be delivered through minimally invasive procedures and even percutaneous procedures. Such replacement valves often include a tissue-based valve body that is connected to an expandable frame that is then delivered to the native valve's annulus.
These replacement valves are often intended to at least partially block blood flow. However, a problem occurs when blood flows around the valve on the outside of the prosthesis. An additional challenge relates to the ability of such prostheses to be secured relative to intralumenal tissue, e.g., tissue within any body lumen or cavity, in an atraumatic manner.
Embodiments of the present disclosure are directed to an anchoring system for a prosthesis, such as but not limited to a replacement heart valve. In some embodiments, an anchor for a replacement heart valve prosthesis can include a frame and a tether for attachment to a replacement heart valve prosthesis. The frame can have one or more wings extending upwardly from a lower end. The frame can have a generally conical shape to generally conform to the shape of the heart.
In some embodiments, a chordal replacement system can include a frame and a tether for attachment to a leaflet of a native mitral valve. The frame can have one or more wings extending upwardly from a lower end. The frame can have a generally conical shape to generally conform to the shape of the heart.
In some embodiments, a method of performing a procedure at a patient's heart can include delivering an anchor frame to an apex of the heart. The anchor frame can have one or more wings extending upwardly from a lower end. The frame can have a generally conical shape. The method can further include expanding the anchor frame, seating the lower end of the anchor frame against the apex of the heart, and applying tension to a tether connecting the anchor frame to a location within a chamber of the patient's heart, such as a replacement heart valve within a chamber of the patient's heart or native leaflets within a chamber of the patient's heart.
These and other features, aspects and advantages are described below with reference to the drawings, which are intended to illustrate embodiments of prostheses including embodiments of various components of these prostheses.
The present specification and drawings provide aspects and features of the disclosure in the context of several embodiments of anchoring systems, prostheses, replacement heart valves, and methods that are configured for use in the vasculature of a patient, such as for replacement of natural heart valves in a patient. These embodiments may be discussed in connection with replacing specific valves such as the patient's mitral valve. However, it is to be understood that the features and concepts discussed herein can be applied to replacing other types of valves including, but not limited to, the aortic valve, the pulmonary valve, and the tricuspid valve. Moreover, it is to be understood that the features and concepts discussed herein can be applied to products other than heart valve implants. For example, the controlled positioning, deployment, and/or securing features described herein can be applied to medical implants, for example other types of expandable prostheses, for use elsewhere in the body, such as within a vein, or the like. In addition, particular features of a prosthesis should not be taken as limiting, and features of any one embodiment discussed herein can be combined with features of other embodiments as desired and when appropriate.
Certain terminology may be used in the following description for the purpose of reference only, and thus are not intended to be limiting. For example, terms such as “upper”, “lower”, “upward”, “downward”, “above”, “below”, “top”, “bottom” and similar terms refer to directions in the drawings to which reference is made. Terms such as “proximal”, “distal”, “radially outward”, “radially inward”, “outer”, “inner”, and “side”, describe the orientation and/or location of portions of the components or elements within a consistent but arbitrary frame of reference, which is made clear by reference to the text and the associated drawings describing the components or elements under discussion. Such terminology may include the words specifically mentioned above, derivatives thereof, and words of similar import. Similarly, the terms “first”, “second”, and other such numerical terms referring to structures neither imply a sequence or order unless clearly indicated by the context.
In some embodiments, the term “proximal” may refer to the parts of the prostheses, or components thereof, which are located closer to the operator of the device and system (e.g., the clinician implanting the prosthesis). The term “distal” may refer to the parts of the prostheses, or components thereof, which are located further from the operator of the device and system (e.g., the clinician implanting the prosthesis). However, it is to be understood that this terminology may be reversed depending on the delivery technique utilized (e.g., a transapical approach as compared to a transseptal approach).
With reference first to
As shown in the illustrated embodiment, the frame 110 can have a wireform shape bent to have one or more upper apices 114a-c and one or more lower apices 116a-c. The wireform shape of the frame 110 can advantageously allow the frame 110 to collapse into a small diameter during delivery to a target anchoring site. Moreover, the wireform shape of the frame 110 can allow parts of the frame 110 to deform without significantly affecting other parts of the frame 110. The wireform can be manufactured from metals such as nitinol or stainless steel, polymers such as polytetrafluoroethylene (PTFE), and/or other biocompatible materials. The wireform can include a covering (not shown) such as a soft biocompatible material, including but not limited to a fabric or polymer.
As shown in
The size, shape, and/or construction of the frame 110 helps ensure that the frame 110 distributes anchoring forces over a relatively large area on the heart 10, thereby reducing pressures applied to the heart 10. In some embodiments, the frame 110 can distribute anchoring forces along non-apical portions of the heart 10 in lieu of, or in addition to, anchoring forces along the apex 20 of the heart 10. This reduces the likelihood that the natural, conical shape of the heart 10 is deformed into a shape with reduced pumping performance. For example, the distribution of loads along non-apical portions of the heart 10 can reduce the likelihood that the apex is pulled inwardly, which can flatten the bottom of the ventricle. In some embodiments, the frame 110 can be deformable to better conform to the shape of the heart 10. As noted above, the frame 110 can be formed from a flexible wireform and/or covering, which can allow the frame 110 to better conform to the shape of the heart 10. This can be particularly advantageous since the heart 10 dynamically alters its shape throughout the cardiac cycle (e.g., diastole and systole). The deformable characteristic of the frame 110 can allow the frame 110 to maintain a substantial contact area with the heart 10 throughout these various phases. Moreover, the wire structure of the frame 110 and individual wings 112a-c can allow parts of the frame 110 to deform without substantially affecting other parts of the frame 110. This can enhance conformance of the frame 110 with the heart 10.
As shown in
With reference next to
With reference next to
With reference next to
With reference next to
In some embodiments, the frame 510 can include a covering, such as a soft biocompatible material, including but not limited to a fabric or polymer. The large surface area of the frame 510 can help ensure that the frame 510 distributes anchoring forces over a relatively large area on the heart, thereby reducing pressures applied to the heart. A tether (not shown) can extend from the base 511a.
With reference next to
With reference next to
In some embodiments, the tether adjustment mechanism 630 can be wirelessly powered. For example, the tether adjustment mechanism 630 can allow for inductive power transfer. In some embodiments, a battery can be omitted thereby extending the usable lifespan of the tether adjustment mechanism 630; however, it is to be understood that a battery can be used in combination with, or in lieu of, inductive power transfer. Power can be transmitted inductively to the tether adjustment mechanism 630 via one or more antennas 646.
As shown in
With reference next to
As shown in the illustrated embodiment, the tether adjustment mechanism 730 can be driven via an external magnetic field. A magnetic wheel 740 can be operated via a magnetic force supplied externally. For example, a remote controller can create a rotating magnetic field to rotate the wheel 740. The wheel 740 can include teeth 741 that engage complementary teeth of a sprocket or gear 742. The sprocket or gear 742 can rotatably drive a second sprocket or gear 744 having a worm gear. The worm gear can rotate the screw drive 738 to adjust the height of the piston. Use of a magnetically driven motor can beneficially reduce the amount of electronics contained within the tether adjustment mechanism. Although two sprockets 742, 744 are shown, the number of sprockets can be varied as desired.
With reference next to
With reference next to
With reference next to
While the embodiments of anchoring systems described above can be maintained on the patient's heart permanently, or at least while the replacement valve remains in position, it is to be understood that components of the anchoring system, such as the frame or tether, can be temporary. In some embodiments, the frame and/or tether can be removed from the heart after the replacement valve is securely maintained in the native valve. For example, the replacement valve can be designed to allow tissue ingrowth to further secure the replacement valve to the native valve. The frame and/or tether can be removed after a desired amount of tissue ingrowth has occurred. This can further reduce the likelihood that the shape of the heart is affected due to contact with the frame and/or tether.
While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of the disclosure. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms. Furthermore, various omissions, substitutions and changes in the systems and methods described herein may be made without departing from the spirit of the disclosure. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope of the disclosure. Accordingly, the scope of the present disclosure is defined only by reference to the claims presented herein or as presented in the future.
Features, materials, characteristics, or groups described in conjunction with a particular aspect, embodiment, or example are to be understood to be applicable to any other aspect, embodiment or example described in this section or elsewhere in this specification unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The protection is not restricted to the details of any foregoing embodiments. The protection extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
Furthermore, certain features that are described in this disclosure in the context of separate implementations can also be implemented in combination in a single implementation. Conversely, various features that are described in the context of a single implementation can also be implemented in multiple implementations separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations, one or more features from a claimed combination can, in some cases, be excised from the combination, and the combination may be claimed as a subcombination or variation of a subcombination.
For purposes of this disclosure, certain aspects, advantages, and novel features are described herein. Not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, for example, those skilled in the art will recognize that the disclosure may be embodied or carried out in a manner that achieves one advantage or a group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements, and/or steps are included or are to be performed in any particular embodiment.
Conjunctive language such as the phrase “at least one of X, Y, and Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to convey that an item, term, etc. may be either X, Y, or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require the presence of at least one of X, at least one of Y, and at least one of Z.
Language of degree used herein, such as the terms “approximately,” “about,” “generally,” and “substantially” as used herein represent a value, amount, or characteristic close to the stated value, amount, or characteristic that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount. As another example, in certain embodiments, the terms “generally parallel” and “substantially parallel” refer to a value, amount, or characteristic that departs from exactly parallel by less than or equal to 15 degrees, 10 degrees, 5 degrees, 3 degrees, 1 degree, or 0.1 degree.
The scope of the present disclosure is not intended to be limited by the specific disclosures of preferred embodiments in this section or elsewhere in this specification, and may be defined by claims as presented in this section or elsewhere in this specification or as presented in the future. The language of the claims is to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive.
This application is a continuation of International Application No. PCT/US2019/014554, filed Jan. 22, 2019, which designates the United States and was published in English by the International Bureau on Jul. 25, 2019 as WO 2019/144121, which claims the benefit of U.S. Provisional Application No. 62/620,367, filed Jan. 22, 2018.
Number | Name | Date | Kind |
---|---|---|---|
3671979 | Moulopoulos | Jun 1972 | A |
3689942 | Rapp | Sep 1972 | A |
3898701 | La Russa | Aug 1975 | A |
4306319 | Kaster | Dec 1981 | A |
4407271 | Schiff | Oct 1983 | A |
5167239 | Cohen et al. | Dec 1992 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5554184 | Machiraju | Sep 1996 | A |
5607465 | Camilli | Mar 1997 | A |
5735842 | Krueger et al. | Apr 1998 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5961440 | Schweich, Jr. | Oct 1999 | A |
6050972 | Zadno-Azizi et al. | Apr 2000 | A |
6210432 | Solem et al. | Apr 2001 | B1 |
6214029 | Thill | Apr 2001 | B1 |
6217567 | Zadno-Azizi et al. | Apr 2001 | B1 |
6287334 | Moll et al. | Sep 2001 | B1 |
6290674 | Roue | Sep 2001 | B1 |
6312464 | Navia | Nov 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6540782 | Snyders | Apr 2003 | B1 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6808483 | Ortiz et al. | Oct 2004 | B1 |
6869444 | Gabbay | Mar 2005 | B2 |
6875224 | Grimes | Apr 2005 | B2 |
6994092 | van der Burg et al. | Feb 2006 | B2 |
7004958 | Adams et al. | Feb 2006 | B2 |
7011669 | Kimblad | Mar 2006 | B2 |
7011682 | Lashinski et al. | Mar 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7070616 | Majercak et al. | Jul 2006 | B2 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7160322 | Gabbay | Jan 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7217287 | Wilson et al. | May 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
7291168 | Macoviak et al. | Nov 2007 | B2 |
7303526 | Sharkey | Dec 2007 | B2 |
7320665 | Vijay | Jan 2008 | B2 |
7322957 | Kletschka et al. | Jan 2008 | B2 |
7381220 | Macoviak et al. | Jun 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7559936 | Levine | Jul 2009 | B2 |
7678145 | Vidlund et al. | Mar 2010 | B2 |
7758596 | Oz et al. | Jul 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7815580 | Viswanathan | Oct 2010 | B2 |
7854762 | Speziali et al. | Dec 2010 | B2 |
7887477 | Nikolic | Feb 2011 | B2 |
7901454 | Kapadia et al. | Mar 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7942928 | Webler et al. | May 2011 | B2 |
8007428 | Vijay | Aug 2011 | B2 |
8052751 | Aklog et al. | Nov 2011 | B2 |
8070805 | Vidlund et al. | Dec 2011 | B2 |
8092525 | Eliasen et al. | Jan 2012 | B2 |
8133213 | Lashinski | Mar 2012 | B2 |
8172856 | Eigler et al. | May 2012 | B2 |
8216302 | Wilson et al. | Jul 2012 | B2 |
8348963 | Wilson | Jan 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8460370 | Zakay | Jun 2013 | B2 |
8486136 | Maurer et al. | Jul 2013 | B2 |
8579967 | Webler et al. | Nov 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8758430 | Ferrari et al. | Jun 2014 | B2 |
8758432 | Solem | Jun 2014 | B2 |
8778017 | Eliasen et al. | Jul 2014 | B2 |
8784482 | Rahdert et al. | Jul 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8888844 | Eliasen et al. | Nov 2014 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8968395 | Hauser et al. | Mar 2015 | B2 |
9161837 | Kapadia | Oct 2015 | B2 |
9232998 | Wilson et al. | Jan 2016 | B2 |
9232999 | Maurer et al. | Jan 2016 | B2 |
9259317 | Wilson et al. | Feb 2016 | B2 |
9289297 | Wilson et al. | Mar 2016 | B2 |
9474605 | Rowe et al. | Oct 2016 | B2 |
9579199 | Hauser et al. | Feb 2017 | B2 |
9636223 | Khalil et al. | May 2017 | B2 |
9681951 | Ratz et al. | Jun 2017 | B2 |
10583009 | Hauser et al. | Mar 2020 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010037129 | Thill | Nov 2001 | A1 |
20020013571 | Goldfarb | Jan 2002 | A1 |
20020128708 | Northrup et al. | Sep 2002 | A1 |
20020198594 | Schreck | Dec 2002 | A1 |
20030050682 | Sharkey | Mar 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030078654 | Taylor et al. | Apr 2003 | A1 |
20030120341 | Shennib et al. | Jun 2003 | A1 |
20030187494 | Loaldi | Oct 2003 | A1 |
20040019378 | Hlavka et al. | Jan 2004 | A1 |
20040024414 | Downing | Feb 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040098081 | Landreville et al. | May 2004 | A1 |
20040117032 | Roth | Jun 2004 | A1 |
20040143294 | Corcoran | Jul 2004 | A1 |
20040167539 | Kuehn et al. | Aug 2004 | A1 |
20040193259 | Gabbay | Sep 2004 | A1 |
20040225233 | Frankowski et al. | Nov 2004 | A1 |
20040243229 | Vidlund et al. | Dec 2004 | A1 |
20040267280 | Nishide et al. | Dec 2004 | A1 |
20050038508 | Gabbay | Feb 2005 | A1 |
20050038509 | Ashe | Feb 2005 | A1 |
20050070999 | Spence | Mar 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050125032 | Whisenant | Jun 2005 | A1 |
20050192627 | Whisenant | Sep 2005 | A1 |
20050267524 | Chanduszko | Dec 2005 | A1 |
20060058871 | Zakay et al. | Mar 2006 | A1 |
20060135966 | Schaller | Jun 2006 | A1 |
20060199995 | Vijay | Sep 2006 | A1 |
20060201519 | Frazier et al. | Sep 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060293739 | Vijay | Dec 2006 | A1 |
20070032821 | Chin-Chen | Feb 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070162071 | Burkett et al. | Jul 2007 | A1 |
20070198082 | Kapadia et al. | Aug 2007 | A1 |
20070219627 | Chu et al. | Sep 2007 | A1 |
20070255399 | Eliasen et al. | Nov 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20070270943 | Solem et al. | Nov 2007 | A1 |
20070282429 | Hauser et al. | Dec 2007 | A1 |
20080077180 | Kladakis | Mar 2008 | A1 |
20080195126 | Solem | Aug 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20090048668 | Wilson et al. | Feb 2009 | A1 |
20090054723 | Khairkhahan | Feb 2009 | A1 |
20090069885 | Rahdert et al. | Mar 2009 | A1 |
20090099596 | McGuckin, Jr. | Apr 2009 | A1 |
20090137968 | Rottenberg | May 2009 | A1 |
20100022948 | Wilson et al. | Jan 2010 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100198347 | Zakay et al. | Aug 2010 | A1 |
20100298929 | Thornton et al. | Nov 2010 | A1 |
20110077733 | Solem | Mar 2011 | A1 |
20110098525 | Kermode | Apr 2011 | A1 |
20110184512 | Webler et al. | Jul 2011 | A1 |
20110224784 | Quinn | Sep 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20120143320 | Eliasen et al. | Jun 2012 | A1 |
20130338763 | Rowe et al. | Dec 2013 | A1 |
20140277390 | Ratz et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20160143736 | Vidlund et al. | May 2016 | A1 |
20170079790 | Vidlund | Mar 2017 | A1 |
20170312078 | Krivoruchko | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
1472996 | Nov 2004 | EP |
2728457 | Jun 1996 | FR |
9930647 | Jun 1999 | WO |
0047139 | Aug 2000 | WO |
02062236 | Aug 2002 | WO |
03003949 | Jan 2003 | WO |
03028558 | Apr 2003 | WO |
03049619 | Jun 2003 | WO |
03003949 | Jan 2004 | WO |
2004012583 | Feb 2004 | WO |
2004014258 | Feb 2004 | WO |
2004021893 | Mar 2004 | WO |
2004030568 | Apr 2004 | WO |
2004045378 | Jun 2004 | WO |
2005007036 | Jan 2005 | WO |
2005027797 | Mar 2005 | WO |
2005069850 | Aug 2005 | WO |
2006032051 | Mar 2006 | WO |
2006049629 | May 2006 | WO |
2006111391 | Oct 2006 | WO |
2006127509 | Nov 2006 | WO |
2007050256 | May 2007 | WO |
2011097355 | Aug 2011 | WO |
2015012122 | Jan 2015 | WO |
Number | Date | Country | |
---|---|---|---|
20200352718 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
62620367 | Jan 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2019/014554 | Jan 2019 | US |
Child | 16934401 | US |